Impact of folic acid and Calomide-Me on urinary protein in patients with H type hypertensive nephropathy
Xue Yu
Abstract
Xue Yu
Abstract
Objective To investigate the impact of folic acid and Calomide-Me on urinary protein in patients with H type hypertensive nephropathy.Methods 94 patients with hypertensive nephropathy in our hospital were selected and divided into folic acid group(n=30),Calomide-Me group(n=31)and folic acid puls Calomide-Me group(n=3),according to the different kinds of drugs given to them.All of the patients were treated for 3 months on the base of routine decompression treatment,and more,HCY,BUN,SCr and 24hU-Pro of these patients were assay and compared before and after treatment.Results(1)After 3 months of treatment,HCY of the patients in the three groups were all reduced significantly(P 0.01),especially in the folic acid puls Calomide-Me group(P 0.05).(2)After treatment,there were no significant improvement on BUN,SCr of the patients in the three groups(P 0.05),however,24hU-Pro of the patients in the three groups were all reduced significantly(P 0.05),especially in the folic acid puls Calomide-Me group(P 0.01).Conclusion Using folic acid and Calomide-Me in patients with H type hypertensive nephropathy may reduce Hcy level of patients,meanwhile,may reduce urinary protein excretion in different degree and protect kidney.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the impact of folic acid and Calomide-Me on urinary protein in patients with H type hypertensive nephropathy.Methods 94 patients with hypertensive nephropathy in our hospital were selected and divided into folic acid group(n=30),Calomide-Me group(n=31)and folic acid puls Calomide-Me group(n=3),according to the different kinds of drugs given to them.All of the patients were treated for 3 months on the base of routine decompression treatment,and more,HCY,BUN,SCr and 24hU-Pro of these patients were assay and compared before and after treatment.Results(1)After 3 months of treatment,HCY of the patients in the three groups were all reduced significantly(P 0.01),especially in the folic acid puls Calomide-Me group(P 0.05).(2)After treatment,there were no significant improvement on BUN,SCr of the patients in the three groups(P 0.05),however,24hU-Pro of the patients in the three groups were all reduced significantly(P 0.05),especially in the folic acid puls Calomide-Me group(P 0.01).Conclusion Using folic acid and Calomide-Me in patients with H type hypertensive nephropathy may reduce Hcy level of patients,meanwhile,may reduce urinary protein excretion in different degree and protect kidney.
Key concepts: Medicine, Folic acid, Internal medicine, Nephropathy, Urinary system, Gastroenterology, Hypertensive Nephropathy, Folic acid supplementation